John Finn, PhDChief Scientific Officer at Basecamp ResearchSpeaker
Profile
John brings over 25 years of experience in gene and cell therapy. He has led scientific teams at Intellia Therapeutics, Codiak Biosciences, and Tome Biosciences, developing cutting-edge gene editing and delivery platforms. John is a pioneer in programmable gene insertion (PGI), with a decade of innovation in advancing its applications.
